Guardion Launches Second Ocular Health Formula ‘GlaucoCetin’
04. Juni 2019 07:00 ET
|
Guardion Health Sciences, Inc.
In an IRB-approved trial conducted at the New York Eye and Ear Infirmary, the parent compound of GlaucoCetin, GlaucoHealth, designed by Robert Ritch, MD, successfully reversed mitochondrial...